MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 138199-71-0
Formula C36H42F2N6O9MW 740.7Research-use catalog entryCOA/SDS by request

Levofloxacin Hydrate

CAS Number: 138199-71-0

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
10 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
500 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: SUIQUYDRLGGZOL-RCWTXCDDSA-NC36H42F2N6O9 | MW 740.7

Chemical Absolute Identifiers

CAS Number

138199-71-0

PubChem CID

3033924

Molecular Formula

C36H42F2N6O9

Molecular Weight

740.7 g/mol

Exact Mass

740.298133

InChIKey

SUIQUYDRLGGZOL-RCWTXCDDSA-N

IUPAC Name

bis((2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid);hydrate

SMILES String

C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.O

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Levofloxacin Hydrate (CAS 138199-71-0) is listed in the Advanced Chemicals portfolio, with molecular formula C36H42F2N6O9 and molecular weight 740. 70 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research building-block and synthetic chemistry workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Natural Product ResearchSynthetic ChemistryResearch intermediateCustom synthesis building blockResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: DNA topoisomerase 2-beta (Homo sapiens) — 3 assays; DNA gyrase (Staphylococcus aureus) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

DNA topoisomerase 2-beta

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 2 documents

Experimental evidence source: ChEMBL

DNA gyrase

Staphylococcus aureus · PROTEIN COMPLEX · 2 qualifying assays · 2 documents

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Levofloxacin Hydrate

Names & Synonyms

(3S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid hemihydrateDynaquinLevofloxacin (hydrate)(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrate(2:1)7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (3S)-
Show all synonyms
Levaquin (TN)(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hemihydrate7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-hydrate (2:1), (S)-Levofloxacin [USAN]RWJ 25213Levofloxacin (USP)Quixin (TN)Iquix (TN)LevofloxacinHemihydrateLevofloxacin hemihydrate CRSLEVOFLOXACIN [VANDF]LEVOFLOXACIN [MART.](S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hydrate (2:1)Levofloxacin hydrate (JP18)LEVOFLOXACIN [USP-RS]
External Identifiers
EC NUMBER: 604-067-2DSSTOX SUBSTANCE ID: DTXSID60160533UNII: 6GNT3Y5LMFKEGG ID: D00588WIKIDATA ID: Q47495791
Experimental Spectrum References
FTIR Spectra — Forensic Spectral ResearchRaman Spectra
Literature & Patent References
DOI 10.1016/j.bmcl.2010.12.073Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives.PMID 21232952Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives.DOI 10.1016/j.bmc.2010.06.098Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents.DOI 10.1016/j.bmc.2010.08.003QSAR-based solubility model for drug-like compounds.DOI 10.1016/j.bmc.2010.10.039Novel lipophilic 7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid derivatives as potential antitumor agents: improved synthesis and in vitro evaluation.DOI 10.1016/j.bmcl.2010.07.006Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines.DOI 10.1016/j.ejmech.2009.09.024Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety.DOI 10.1016/j.ejmech.2010.05.069A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Danofloxacin MesylateCAS 119478-55-6

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 109-01-31-MethylpiperazineCAS 100986-89-8Levofloxacin q-acidCAS 112811-59-3GatifloxacinCAS 70458-96-7NorfloxacinCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acidCAS 1018144-00-72-(3-Cyclopropyl-6-isopropyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 138199-71-0

What are the key identifiers for Levofloxacin Hydrate (CAS 138199-71-0)?

Levofloxacin Hydrate is identified by CAS 138199-71-0, with molecular formula C36H42F2N6O9, molecular weight 740.7, InChIKey SUIQUYDRLGGZOL-RCWTXCDDSA-N.

Does CAS 138199-71-0 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with DNA topoisomerase 2-beta, DNA gyrase. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 138199-71-0?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Levofloxacin Hydrate?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 138199-71-0 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.